145 related articles for article (PubMed ID: 9402482)
21. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
Peng YC; Chan CS; Chen GH
Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal hamartomas of the liver may be associated with increased serum alpha foetoprotein concentrations and mimic hepatoblastomas.
Boman F; Bossard C; Fabre M; Diab N; Bonnevalle M; Boccon-Gibod L
Eur J Pediatr Surg; 2004 Feb; 14(1):63-6. PubMed ID: 15024683
[TBL] [Abstract][Full Text] [Related]
23. [Alpha-fetoprotein: diagnostic value in hepatic disorders].
Kreczko S; Lipska A; Wysocka J
Pol Merkur Lekarski; 2000 Jun; 8(48):420-3. PubMed ID: 10967924
[TBL] [Abstract][Full Text] [Related]
24. Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review.
Wu JT
Ann Clin Lab Sci; 1990; 20(2):98-105. PubMed ID: 1691611
[TBL] [Abstract][Full Text] [Related]
25. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
26. Alpha fetoprotein levels in newborn infants with reference to sex, gestational age and birth weight.
Bansal V; Kumari K; Dixit A; Sahib MK
Indian J Exp Biol; 1989 Jul; 27(7):666-7. PubMed ID: 2483717
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of alphafetoprotein microheterogeneity in alphafetoprotein-secreting tumors.
Saraswathi A; Malati T
Cancer Detect Prev; 1994; 18(6):447-54. PubMed ID: 7532546
[TBL] [Abstract][Full Text] [Related]
28. Two cases of primary yolk sac tumor of the liver in childhood: case reports and literature review.
Warren M; Thompson KS
Pediatr Dev Pathol; 2009; 12(5):410-6. PubMed ID: 19284801
[TBL] [Abstract][Full Text] [Related]
29. Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis.
Sell S; Becker FF; Leffert HL; Watabe L
Cancer Res; 1976 Nov; 36(11 Pt. 2):4239-49. PubMed ID: 61804
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
31. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
32. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
33. Alpha fetoprotein is increasing with age in ataxia-telangiectasia.
Stray-Pedersen A; Borresen-Dale AL; Paus E; Lindman CR; Burgers T; Abrahamsen TG
Eur J Paediatr Neurol; 2007 Nov; 11(6):375-80. PubMed ID: 17540590
[TBL] [Abstract][Full Text] [Related]
34. [Value of alpha 1-fetoprotein (AFP) determination with an ultramicro-ELISA immunoassay in chronic liver diseases with special reference to hepatocellular cancer].
Reinhardt M; Schulze M; Machnik G; Jorke D; Laske V; Krombholz B; Kappauf G; Schröder S
Dtsch Z Verdau Stoffwechselkr; 1987; 47(5):230-41. PubMed ID: 2449324
[TBL] [Abstract][Full Text] [Related]
35. Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Yin ZF; Tu ZX; Cui ZF; Wu MC
Chin Med J (Engl); 1993 Aug; 106(8):615-8. PubMed ID: 7693403
[TBL] [Abstract][Full Text] [Related]
36. The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.
Duffy KA; Deardorff MA; Kalish JM
Am J Med Genet A; 2017 Mar; 173(3):581-584. PubMed ID: 28160403
[TBL] [Abstract][Full Text] [Related]
37. Congenital Hepatoblastoma and Beckwith-Wiedemann Syndrome.
Zivot A; Edelman M; Glick R; Hong A; Fish JD
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e798-e800. PubMed ID: 31335825
[TBL] [Abstract][Full Text] [Related]
38. Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.
Mussa A; Duffy KA; Carli D; Ferrero GB; Kalish JM
Pediatr Blood Cancer; 2019 Jan; 66(1):e27492. PubMed ID: 30270492
[TBL] [Abstract][Full Text] [Related]
39. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience.
De Ioris M; Brugieres L; Zimmermann A; Keeling J; Brock P; Maibach R; Pritchard J; Shafford L; Zsiros J; Czaudzerna P; Perilongo G
Eur J Cancer; 2008 Mar; 44(4):545-50. PubMed ID: 18166449
[TBL] [Abstract][Full Text] [Related]
40. [Preliminary investigations of the serum alpha-1-fetoprotein level in mature and premature newborn infants (author's transl)].
Bugajer-Gleitman HE; Eder G; Lachmann D; Pollak A
Wien Klin Wochenschr; 1975 Oct; 87(18):601-5. PubMed ID: 56817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
